Andere talen Biodesix, Inc.

Aandelen

BDSX

US09075X1081

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,26 ^USD	0,00%		+0,80%	-31,52%

05/04	Top Middag Decliners	MT
25/03	Biodesix sluit nieuwe onderzoeksovereenkomst met Memorial Sloan Kettering Cancer Center	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024	24/04
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting	09/04
Biodesix, Inc. announced that it has received $34.999422 million in funding	09/04
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement	08/04
Top Midday Decliners	05/04
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement	05/04
Biodesix, Inc. announced that it expects to receive $34.999422 million in funding	05/04
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center	25/03
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center	25/03
Biodesix Announces New Master Collaborative Research Agreement with Memorial Sloan Kettering Cancer Center	25/03
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights	04/03
Biodesix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/03
Biodesix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/03
Biodesix, Inc. Provides Revenue Guidance for the Year 2024	01/03
Earnings Flash (BDSX) BIODESIX Posts Q4 Revenue $14.7M	01/03
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights	01/03
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference	26/02
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024	16/02
Biodesix : New Financial Obligation - Form 8-K	20/12
Biodesix Enhances Access to Nodify Lung Testing with Launch of New Blood Draw Method	15/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biodesix, Inc.

Aandelen

BDSX

US09075X1081

Andere talen

Filters